J Pediatr Neurol
DOI: 10.1055/s-0039-1687882
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Dexmedetomidine for Postoperative Sedation Following Stereotactic Lead Placement

Hope Xu*
1  Department of Pediatrics, Icahn School of Medicine at Mount Sinai, Kravis Children's Hospital at Mount Sinai, New York, New York, United States
,
Anthony H. Bui*
1  Department of Pediatrics, Icahn School of Medicine at Mount Sinai, Kravis Children's Hospital at Mount Sinai, New York, New York, United States
,
Maite La Vega-Talbott
2  Department of Neurology, Pediatric Neurology, Kravis Children's Hospital at Mount Sinai, New York, New York, United States
,
Sheemon P. Zackai
3  Department of Pediatrics, Pediatric Critical Care Medicine, Kravis Children's Hospital at Mount Sinai, New York, New York, United States
› Author Affiliations
Further Information

Publication History

15 January 2019

18 March 2019

Publication Date:
30 April 2019 (online)

Abstract

Dexmedetomidine has become an increasingly popular alternative to benzodiazepines and opioids as a safe agent for sedation and pain control, especially in pediatric populations. In this study, we present a case of postoperative use of dexmedetomidine in a pediatric patient, with a known history of behavioral difficulties, who underwent stereotactic lead placement for medically refractory epilepsy.

* Equal contribution